Incoming information from the retina is channeled into two pathways in the brain's visual system: one that's responsible for ...

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

A custom scleral lens system improves visual acuity and comfort in patients with a variety of corneal conditions, research ...

Zenlens custom scleral contact lenses improved visual acuity and yielded more than 11 hours of comfortable wearing time, ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

Researchers link early cone dysfunction in RPGR-related retinal dystrophy to high myopia, with timing of degeneration ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

A novel eye drop formulation shows antioxidant effects and may protect corneal epithelial cells, according to research presented at AOA 2025.

Auckland District Health Board, New Zealand (Dr D Squirrell); AUBMC, Lebanon (Dr Z Bashshur and Dr W Kheir); Adelaide Eye and Retina Centre, South Australia (Professor J Gilhotra); Al Watany Eye ...

Article Published: May 1998 Molecular genetics of human retinal dystrophies Chris F Inglehearn Eye 12, 571–579 (1998) Cite this article ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular"), a biopharmaceutical company committed to redefining the retina experience, announced the launch of ...

Night blindness is caused by vitamin A deficiency, congenital mutations, and other eye diseases. Learn about symptoms, causes ...